Though current clinical parameters for diagnosis are incapable of accurately predicting patient outcomes, recent evidence has revealed chemerin's prognostic value in gastric cancer, as well as its functions in tumor growth (67). The gene discussed is RARRES2; the disease is gastric cancer.